Voyager Therapeutics, Inc. Debt Conversion, Converted Instrument, Amount
Voyager Therapeutics, Inc. (VYGR) reported Debt Conversion, Converted Instrument, Amount of $150.19 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-17.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2017-03-15
- Voyager Therapeutics, Inc. debt conversion, converted instrument, amount for the quarter ending 2014-12-31 was $0.00.
- Voyager Therapeutics, Inc. debt conversion, converted instrument, amount for fiscal 2015 was $150.19M, a 5027.59% increase from fiscal 2014.
- Voyager Therapeutics, Inc. debt conversion, converted instrument, amount for fiscal 2014 was $2.93M.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|
| 2015-12-31 | $150.19M 10-K · filed 2016-03-17 | ||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $2.93M 10-K · filed 2017-03-15 | |
| 2014-09-30 | $2.93M 10-Q · filed 2015-12-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |